Avalun begins scaling up its LabPad® for manufacturing

Avalun, which received support from the French government’s investissements d’avenir program in 2016, is growing! The Leti spinoff, founded in 2013, recently moved into the BHT, where it will have a modular space of 175 sq. m, an 80 sq. m lab, and 70 sq. m of offices. In other words, everything it needs to start scaling up its LabPad® connected pocket-sized biological analysis device.

The company will set up a test production line for its Tsmart® microcuvettes for prothrombin ratio (PR) and international normalized ratio (INR) tests (which indicate blood clotting time) at the BHT in April. Production will be manual to start, and will be automated over the course of the year. By the end of 2017 Avalun, which will manufacture and sell the consumables, plans to reach output of 5,000 units per day.

Avalun, which currently employs 18 people, will hire six new employees (in R&D, sales, and marketing) to support this new phase in its development.

Contact: contact@avalun.com

Facebook

Twitter